Presentation Information

[L1-01]Knowledge of Academia-Industry Collaboration for the Rapid Development of the Oxford-AstraZeneca Vaccine"

*Atsushi Maruyama1, Jun Honda2 (1. Vaccines & Immune Therapies, Medical Affairs, AstraZeneca (Japan), 2. External Operations Vaccines and Immune Therapies Operations, External Supply & Manufacturing, AstraZeneca (Japan))

Login required to view

Login is required to view some content.

Comment

To browse or post comments, you must log in.Log in